Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial

Sl Charland,Barnabie C Agatep,V. Herrera,Bruce J Schrader,Felix W. Frueh,M Ryvkin,J Shabbeer,James J. Devlin,H. Superko,Eric J. Stanek

Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial

2014

Sl Charland
Barnabie C Agatep
V. Herrera
Bruce J Schrader
Felix W. Frueh
M Ryvkin
J Shabbeer
James J. Devlin
H. Superko
Eric J. Stanek

Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial

Keywords:

Pharmacology
Functional genomics
Statin
Drug development
KIF6
Pharmacogenetic Test
Biology
patient compliance
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pharmacogenetics
statin therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations